Ono has opened a new office in Zug to strengthen its European presence following the acquisition of Deciphera, with the site serving as a regional hub for commercial and pipeline growth.

Ono Pharmaceutical has opened a new 733-square-metre office in Zug to support the company’s growing activities across Europe and partner markets. The launch was marked with a ceremony attended by company management and regional government officials, including Gyo Sagara, Toichi Takino, Ryota Udagawa and Silvia Thalmann-Gut.

Ryota Udagawa, chief executive officer of Deciphera, said: “The opening of our new Zug office marks a key milestone in Deciphera’s journey. Following the Ono acquisition, we have significantly broadened our pipeline with several promising clinical candidates that have the potential to expand our commercial portfolio in the coming years. This office positions us for growth in international markets as we advance these candidates toward commercialisation.”

Udagawa added: “The Zug office plays a key role as our hub in Europe, reinforcing our global footprint and enhancing our ability to better serve communities worldwide. Furthermore, our Zug office was recognised as the Best Workplace in Switzerland in its category in 2025 by Great Place to Work and we believe this new office will further contribute to attract and retain top talent as well as foster teamwork and collaboration.”

Silvia Thalmann-Gut, director of economic affairs for Kanton Zug, said: “I am always very pleased to see companies like Deciphera choose Zug as their international hub and seeing the current expansion of office is a true testament to the incredible biotech and pharma eco-system that was developed over the years and that we will continue to support in the future.”

Deciphera’s international office was established in Zug in 2021 and has since expanded its presence across Europe.